Literature DB >> 21719494

Are COPD patients with pneumonia who are taking inhaled corticosteroids at higher risk of dying?

M I Restrepo, E M Mortensen, A Anzueto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21719494      PMCID： PMC4082328          DOI： 10.1183/09031936.00028711

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  15 in total

1.  Severity prediction rules in community acquired pneumonia: a validation study.

Authors:  W S Lim; S Lewis; J T Macfarlane
Journal:  Thorax       Date:  2000-03       Impact factor: 9.139

2.  Acute exacerbation of chronic obstructive pulmonary disease: more a functional than an inflammatory problem?

Authors:  Tobias Welte
Journal:  Am J Respir Crit Care Med       Date:  2008-01-15       Impact factor: 21.405

3.  Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease.

Authors:  Peter Kardos; Marion Wencker; Thomas Glaab; Claus Vogelmeier
Journal:  Am J Respir Crit Care Med       Date:  2006-10-19       Impact factor: 21.405

4.  Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia.

Authors:  Pierre Ernst; Anne V Gonzalez; Paul Brassard; Samy Suissa
Journal:  Am J Respir Crit Care Med       Date:  2007-03-30       Impact factor: 21.405

5.  A prediction rule to identify low-risk patients with community-acquired pneumonia.

Authors:  M J Fine; T E Auble; D M Yealy; B H Hanusa; L A Weissfeld; D E Singer; C M Coley; T J Marrie; W N Kapoor
Journal:  N Engl J Med       Date:  1997-01-23       Impact factor: 91.245

6.  Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.

Authors:  Peter M A Calverley; Julie A Anderson; Bartolome Celli; Gary T Ferguson; Christine Jenkins; Paul W Jones; Julie C Yates; Jørgen Vestbo
Journal:  N Engl J Med       Date:  2007-02-22       Impact factor: 91.245

7.  Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease.

Authors:  P M Calverley; W Boonsawat; Z Cseke; N Zhong; S Peterson; H Olsson
Journal:  Eur Respir J       Date:  2003-12       Impact factor: 16.671

8.  The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide.

Authors:  Jadwiga A Wedzicha; Peter M A Calverley; Terence A Seemungal; Gerry Hagan; Zainab Ansari; Robert A Stockley
Journal:  Am J Respir Crit Care Med       Date:  2007-10-04       Impact factor: 21.405

9.  Efficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in patients with moderate to very severe chronic obstructive pulmonary disease: results of a 6-month randomized clinical trial.

Authors:  Donald P Tashkin; Stephen I Rennard; Paula Martin; Sulabha Ramachandran; Ubaldo J Martin; Philip E Silkoff; Mitchell Goldman
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 10.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

Authors:  Klaus F Rabe; Suzanne Hurd; Antonio Anzueto; Peter J Barnes; Sonia A Buist; Peter Calverley; Yoshinosuke Fukuchi; Christine Jenkins; Roberto Rodriguez-Roisin; Chris van Weel; Jan Zielinski
Journal:  Am J Respir Crit Care Med       Date:  2007-05-16       Impact factor: 21.405
View more
  3 in total

1.  Effects of inhaled corticosteroids on pneumonia severity and antimicrobial resistance.

Authors:  Oriol Sibila; Elena Laserna; Eric M Mortensen; Antonio Anzueto; Marcos I Restrepo
Journal:  Respir Care       Date:  2013-01-23       Impact factor: 2.258

2.  COPD patients with ventilator-associated pneumonia: implications for management.

Authors:  D Koulenti; S Blot; J M Dulhunty; L Papazian; I Martin-Loeches; G Dimopoulos; C Brun-Buisson; M Nauwynck; C Putensen; J Sole-Violan; A Armaganidis; J Rello
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-09-25       Impact factor: 3.267

3.  Inhaled corticosteroid use in patients with chronic obstructive pulmonary disease and the risk of pneumonia: a retrospective claims data analysis.

Authors:  Barbara P Yawn; Yunfeng Li; Haijun Tian; Jie Zhang; Steve Arcona; Kristijan H Kahler
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2013-06-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.